The chair of this ASX All Ords company just sold $6.5 million of shares. What gives?

busy trader on the phone in front of board depicting asx share price risers and fallersbusy trader on the phone in front of board depicting asx share price risers and fallers

The Rhythm Biosciences Ltd (ASX: RHY) share price is in the green during morning trade on Friday. This comes after the ASX All Ords company announced that its executive chair has just offloaded $6.5 million worth of his shares.

At the time of writing, the medical device company’s shares are trading at $1.375, up 1.85%.

Rhythm chair sells down his stake

Investors are shrugging off the company’s latest news, sending the Rhythm share price higher today.

According to Rhythm’s release, its executive chair Otto Buttula offloaded $6.5 million worth of shares to a domestic institutional fund manager.

While the buyer’s name wasn’t disclosed, the on-market transaction involved 5,000 Rhythm shares sold at $1.30 apiece.

The exclusive share sale came from the Newfound superannuation fund in which Buttula is one of three members.

Rhythm stated that the primary purpose of the sale is to enhance portfolio diversification and better meet trustee, accounting, and auditor advice.

Prior to the sale, the superannuation fund’s holding in Rhythm represented 95.9% of the total assets of the fund and 98.6% of its ASX listed company exposures.

However, now with the sale completed, the superannuation fund holds roughly 6.1 million Rhythm shares and about 2.1 million options at $1.80 each, expiring July 2024.

This is the first time Buttula has reduced his holdings in the ASX All Ords company since his appointment as chair in October 2019.

He also confirmed there is no intention to sell any further shares for the foreseeable future.

What did the chair of this ASX All Ords company say?

Commenting on the sale, Buttula said:

Whilst there is never a perfect time to reduce exposure to a company that you are immensely proud of being a part of, in this case, the numbers speak for themselves and a holding above 95% in one company exposure, particularly in a retirement fund, with two other members, was problematic and not prudent.

Despite the sale, my associated interests continue to maintain the largest shareholding in the company, maintaining a holding of 10.8% (ex-options). Importantly, I am also delighted to welcome another leading fund manager to the RHY register. The institutional fund manager is one of Australia’s most successful and has conducted a period of due diligence on the prospects of the company.

Rhythm share price snapshot

Over the past 12 months, the Rhythm share price has gained 37% but fallen 11% year-to-date.

The company’s shares reached a 2022 low of $1.01 in June before climbing in the weeks thereafter.

At today’s prices, this ASX All Ords share has a market capitalisation of approximately $292.24 million with around 215.67 million shares on issue.

The post The chair of this ASX All Ords company just sold $6.5 million of shares. What gives? appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Oj5ozh2

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *